VALN
Valneva SE ADR
NASDAQ: VALN · HEALTHCARE · BIOTECHNOLOGY
$5.38
+0.94% today
Updated 2026-04-30
Market cap
$480.43M
P/E ratio
—
P/S ratio
2.75x
EPS (TTM)
$-1.59
Dividend yield
—
52W range
$5 – $12
Volume
0.1M
Valneva SE ADR (VALN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-65.90%
Operating margin
-58.10%
ROE
-80.20%
ROA
-11.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $2.33M | $-243000.00 | 68.83% | -9.49% | -10.43% |
| 2007 | $866000.00 | $-3.36M | -94.34% | -552.54% | -388.22% |
| 2008 | $3.42M | $-2.39M | 19.69% | -92.28% | -69.89% |
| 2009 | $3.10M | $-6.14M | -69.80% | -203.33% | -198.45% |
| 2010 | $8.39M | $-7.96M | 22.11% | -100.26% | -94.84% |
| 2011 | $10.26M | $-4.42M | 34.50% | -43.37% | -43.06% |
| 2012 | $3.43M | $-14.84M | -223.38% | -374.03% | -432.56% |
| 2013 | $30.45M | $-24.11M | 45.78% | -68.50% | -79.19% |
| 2014 | $36.92M | $-26.27M | 53.57% | -64.50% | -71.15% |
| 2015 | $78.36M | $-20.62M | 40.07% | -25.44% | -26.31% |
| 2016 | $94.06M | $-49.18M | 54.20% | -45.26% | -52.29% |
| 2017 | $105.29M | $-11.48M | 56.33% | -3.76% | -10.91% |
| 2018 | $113.03M | $3.26M | 61.58% | 5.54% | 2.89% |
| 2019 | $126.20M | $-1.74M | 60.40% | -0.64% | -1.38% |
| 2020 | $110.32M | $-64.39M | 50.78% | -49.95% | -58.37% |
| 2021 | $348.08M | $-73.42M | 46.01% | -17.64% | -21.09% |
| 2022 | $361.30M | $-143.28M | 10.20% | -31.40% | -39.66% |
| 2023 | $153.71M | $-101.43M | 34.37% | -53.40% | -65.99% |
| 2024 | $169.58M | $-12.25M | 41.89% | 7.86% | -7.22% |
| 2025 | $174.66M | $-115.19M | 38.66% | -46.74% | -65.95% |